# Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand

> **NCT00398684** · PHASE3 · COMPLETED · sponsor: **Institut de Recherche pour le Developpement** · enrollment: 1792 (—)

## Conditions studied

- HIV Infections
- Pregnancy

## Interventions

- **DRUG:** Single dose nevirapine to the mother and to the child
- **DRUG:** Single dose nevirapine to the mother and placebo to the child
- **DRUG:** Single dose placebo to the mother and to the child

## Key facts

- **NCT ID:** NCT00398684
- **Lead sponsor:** Institut de Recherche pour le Developpement
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2004-06
- **Target enrollment:** 1792 (—)
- **Last updated:** 2008-05-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398684, "Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00398684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*